13F Pro quality score
Rank #2,475 of 2,925
Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.
BioRestorative Therapies, Inc. (BRTX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores BRTX at 30.0/100 on a composite quality score built from its SEC filings, placing it at rank #2,475 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q1 2026), BioRestorative Therapies, Inc. reports quarterly revenue of $23.2K, net income of $-2.2M. Top institutional holders of BRTX by reported 13-F value include JANE STREET GROUP, HRT FINANCIAL, XTX Topco Ltd, based on the most recent SEC filings. BRTX trades on the Nasdaq exchange and files with the SEC under CIK 1505497. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BRTX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for BioRestorative Therapies, Inc. directly from SEC EDGAR.